As part of the Medisonal Group, our focus remains unwavering: enhancing access to life-unlicensed medicines, such as medical cannabis, for patients in the Czech Republic, Poland and Germany.
Our institute of education (MIE) hosts a wealth of teaching modules to educate healthcare professionals on unlicensed medicines, with a keen focus into the therapeutic potential of Cannabis-Based Prescription Medicines (CBPMs).
The M3 platform acts as a hub of comprehensive informational resources, that can allow doctors to navigate the complexities involved in unlicensed medicines
M2 is an online innovative platform that has been built with the sole purpose of enhancing patient engagement, and providing convenient and interactive access to healthcare services.